12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Other News

Forest Laboratories generics, pharmaceuticals news

Forest Laboratories filed proxy materials for its August 15 annual meeting including a letter to shareholders which recommends voting for the company's 10 nominated directors. Forest also recommended shareholders reject the four nominees put forth by activist investor Carl Icahn. This is the second straight year Icahn has put forth nominees. Separately, Forest Chairman, President and CEO Howard Solomon sent a letter to Icahn addressing issues the activist...

Read the full 318 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >